StemWave

StemWave is a medical technology company that specializes in non-invasive acoustic wave therapy devices designed to alleviate pain and inflammation in patients with musculoskeletal conditions. The company has experienced significant growth, ranking No. 227 on the 2023 Inc. 5000 list with a remarkable three-year revenue growth of 2,460%. Led by CEO Tom Kostopoulos, StemWave operates nationally and is trusted by over 500 medical offices across all 50 states. The core product, the StemWave Device, utilizes Cellular Response Technology (CRT) to deliver low-intensity focused acoustic waves, stimulating the body's natural healing processes. Another product, Modus-F, further enhances treatment options for pain and inflammation. StemWave also offers support programs for healthcare providers, including the StemWave Platinum Provider Program and Fast-Track to Growth Training, aimed at integrating their technology into medical practices and promoting practice growth.